Delivery Order SPE2DB24D1007-SPE2DB25FCCAB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,046.72 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price contract represents a non-set-aside competitive award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,187.36 delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime vendor agreement serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,113.32 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. This non-competitive delivery order was issued on November 24, 2025, with a completion date of November 25, 2025, and reflects a firm fixed price contract structure. The award was fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,113.32 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on December 10, 2025, with completion scheduled for December 11, 2025. This non-competitive, firm fixed price delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the primary pharmaceutical supply...
- The Defense Logistics Agency awarded a $12,764.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg, with an ultimate completion date of August 22, 2025. This competitive award, issued on August 21, 2025, carries no set-aside designation and represents a pharmaceutical supply delivery to be fulfilled at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,910.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg on September 29, 2025, with completion targeted for September 30, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $3,274.38 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication, with a completion date of June 30, 2025. This is a firm fixed price contract with no set-aside designation, awarded competitively on June 27, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $1,105.16 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Januvia 100 mg tablets in a 90-count package. This firm fixed-price contract, which is set to be completed by July 31, 2025, represents a single delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,182.92 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Januvia 100 mg tablets (90-count units). The contract utilizes firm fixed pricing with a non-competitive set-aside and is scheduled for completion by September 29, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical supplier to federal medical procurement systems serving military and veteran...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCABDelivery Order
The Defense Logistics Agency awarded a $2,742.88 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's role as a prime vendor under the DLA Troop Support Medical IDC reflects its capability to meet federal procurement requirements through open competition, delivering diverse pharmaceutical products including brand-name and generic medications across multiple therapeutic domains. The current delivery order for Januvia, a diabetes medication, exemplifies the company's ongoing support of Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to address military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 5/30/25 |